HomeStock ScreenerSHARMEH

SHARMEH Share Price | SHARMEH Stock Screener

SHARMEH Healthcare Service Provider
Share Price BSE
₹100.90
▲ 6.85 (7.28%)
2026-07-24 00:00:00
As of July 24, 2026, the SHARMEH share price (BSE: SHARMEH) is ₹100.90, up 7.28% from the previous close, with shares trading between ₹98.00 and ₹104.90, and a 52-week range of ₹76.06–₹233.90. Analyse SHARMEH share price performance and track historical price performance. Use the SHARMEH stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
SHARMEH Market Cap ₹32.81 Cr.
SHARMEH P/E Ratio (TTM) 25.33
SHARMEH P/B Ratio 2.45
EPS (TTM) ₹3.78
Dividend Yield -
Debt to Equity 0.31
SHARMEH 52 Week High ₹233.90
SHARMEH 52 Week Low ₹76.06
Operating Margin 10.00%
Profit Margin 2.78%
SHARMEH Revenue (TTM) ₹36.00
EBITDA ₹4.00
Net Income ₹1.00
Total Assets ₹33.00
Total Equity ₹14.00

SHARMEH Share Price Chart

Screen SHARMEH share price with an interactive chart. Analyse SHARMEH price trends and volatility across different timeframes.

SHARMEH Company Profile - Fundamental Screener

Screen SHARMEH company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHARMEH shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE465H01012

SHARMEH Balance Sheet Screener

Screen SHARMEH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 33 28 25 24 19 19 20 22 16 18
Current Assets 20 15 7 12 10 11 12 15 8 9
Fixed Assets 8 9 8 9 7 6 4 5 6 6
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 2 2 2 2 1 2 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 14 13 11 11 10 9 8 8 8 8
Share Capital 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 10 8 7 6 5 5 4 4 4 3

SHARMEH Income Statement Screener - Profit & Revenue Analysis

Screen SHARMEH income statement and profit fundamentals. Analyze SHARMEH quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for SHARMEH share price evaluation.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 36 30 24 21 17 11 16 16 16 17 17 17
Expenses 32 26 20 17 15 9 14 14 15 16 16 15
EBITDA 4 4 3 3 2 2 2 2 2 2 1 2
Operating Profit % 10.00% 12.00% -10.00% 16.00% 13.00% -8.00% 12.00% 4.00% 9.00% 10.00% 5.00% 8.00%
Depreciation 2 2 2 1 1 1 0 1 1 1 1 1
Interest 1 1 1 1 1 1 1 1 1 1 1 1
Profit Before Tax 2 1 1 1 1 1 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 1 1 1 1 0 0 0 0 0 1
EPS 3.78 3.79 2.02 2.96 2.07 1.94 1.18 0.81 0.40 0.26 0.09 1.74

SHARMEH Cash Flow Screener - Liquidity Fundamentals

Screen SHARMEH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 7 -1 1 2 1 1 -1 3 1 0
Investing Activities -3 5 -4 -2 3 -2 2 0 -1 0
Financing Activities -4 -4 3 -2 -2 -5 5 -3 0 0
Net Cash Flow 0 0 0 -2 2 -5 5 0 0 0

SHARMEH Shareholding Pattern Screener

See SHARMEH shareholding pattern with promoter, FII, and DII holdings. Check SHARMEH promoter holding and ownership changes for SHARMEH on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 33.33% 33.50% 33.50% 33.49% 33.31% 32.83% 32.83% 32.92%
Other Holding 13.03% 12.86% 12.86% 12.88% 13.06% 13.53% 13.53% 13.44%
Shareholder Count 4,210 4,068 4,147 4,377 4,226 3,698 3,697 3,778

SHARMEH Share Dividend Screener - Share Yield Analysis

Check SHARMEH dividend history with payout and yield data. View SHARMEH dividend details including ex-dates and amounts for SHARMEH stock.
No dividends declared by SHARMEH.

SHARMEH Stock Index Membership

See which indices include SHARMEH stock. Check SHARMEH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
SHARMEH is not part of any tracked indices.
Only major market indices are tracked in our system.

SHARMEH Market Events Screener - Corporate Actions

Get SHARMEH corporate actions including splits, bonuses, and buybacks. Check SHARMEH stock events that may affect SHARMEH share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-30 2026-05-30 Quarterly Result Announcement NA 7.74%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 15.01%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.69%
2025-09-30 2025-09-30 Annual General Meeting NA -19.83%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -4.46%
2025-05-23 2025-05-23 Quarterly Result Announcement NA -1.35%
2025-01-10 2025-01-10 Quarterly Result Announcement NA 10.38%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.86%
2024-09-30 2024-09-30 Annual General Meeting NA -16.46%

SHARMEH Competitors Screener - Peer Comparison

Screen SHARMEH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 28,421 55.45 2,864 12.11% 510 53.89
Vijaya Diagnostic Centre 13,724 79.78 814 16.36% 182 49.85
Metropolis Healthcare 11,884 59.35 1,646 22.25% 185 48.20
Thyrocare Technologies 8,877 50.85 846 20.48% 163 47.89
Nephrocare Health Services 6,321 83.20 999 29.74% 62 41.81
Krsnaa Diagnostics 1,757 17.33 773 4.05% 106 44.46
Suraksha Diagnostic 1,342 42.90 310 21.30% 34 37.28
One Global Service Provider 1,163 16.95 498 237.06% 69 48.09
3B BlackBio DX 1,079 17.90 142 27.17% 61 56.03
Health X Platform 1,015 -706.67 1,319 12.68% -3 50.65

SHARMEH Company Announcements - News Screener

Screen SHARMEH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-22 Closure of Trading Window -
2026-06-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-31 Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 -
2026-05-30 Board Meeting Outcome for Outcome Of Board Meeting Held On May 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations. 2015. -
2026-05-15 Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026. -
2026-04-29 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-27 Closure of Trading Window -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-14 Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025 -
2026-02-14 Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. -
2026-02-05 Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St December 2025 -
2026-01-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-30 Closure of Trading Window -
2025-11-14 Intimation Of Reconstitution Of Audit Committee And Nomination And Remuneration Committee Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2025-11-14 Announcement under Regulation 30 (LODR)-Resignation of Director -
2025-11-14 Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 -
2025-11-14 Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. -
2025-11-04 Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 -